Huadong Pharmaceutical announced at noon on July 20 that Lu Liang, chairman of the company, proposed implementing the 2026 mid-term profit distribution plan, to pay 3.5 yuan in cash to all shareholders for every 10 shares, no bonus shares, and no increase in share capital from capital reserves. Based on the company's current total share capital, the total dividend for the middle of 2026 is expected to be 614 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.